IL-6 AS A MARKER OF CORONARY ARTERY DISEASE IN RHEUMATOID ARTHRITIS PATIENTS WITH CARDIOVASCULAR RISK FACTORS

被引：0
|
作者：
Fomicheva, O. [1 ]
Krougly, L. [1 ]
Sorokin, E. [1 ]
Tsomartova, M. [1 ]
Karpov, Y. U. [1 ]
Gerasimova, E. [2 ]
Novikova, D. [2 ]
Popkova, T. [2 ]
Nasonov, E. [2 ]
机构：
[1] Natl Med Res Ctr Cardiol, Moscow, Russia
[2] VA Nasonova Res Inst Rheumatol, Moscow, Russia
来源：
ATHEROSCLEROSIS | 2018年 / 275卷
关键词：
D O I：
10.1016/j.atherosclerosis.2018.06.794
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P5.6.513
引用
收藏
页码：E249 / E250
页数：2
相关论文
共 50 条
  • [21] Association of interleukin-6 (IL-6)-174G/C polymorphism with cardiovascular disease in patients with rheumatoid arthritis
    Panoulas, Vasileios F.
    Smith, Jacqueline P.
    Douglas, Karen M. J.
    Stavropoulos-Kalinoglou, Antonios
    Metsios, Georgios S.
    Kitas, George D.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S271 - S271
  • [22] Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
    Han, Chenglong
    Robinson, Don W.
    Hackett, Monica V.
    Paramore, L. Clark
    Fraeman, Kathy H.
    Bala, Mohan V.
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (11) : 2167 - 2172
  • [23] Hydroxychloroquine Reduces the Risk of Coronary Artery Disease in Patients with Rheumatoid Arthritis.
    Li Chun
    Mu Rong
    Su Yin
    Li Xiaofeng
    Wang Yongfu
    Wang Guochun
    Zhu Ping
    Liu Xiangyuan
    Chen Haiying
    Cui Liufu
    Zhang Zhuoli
    Li Zhenbin
    Li Junfang
    Zhang Fengxiao
    Han Shuling
    Lin Jinying
    Liu Xiaomin
    Hu Shaoxian
    Yang Xiuyan
    Huang Cibo, Sr.
    Li Xingfu
    Wang Yi
    Li Zhanguo
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S538 - S539
  • [24] Impact of rheumatoid arthritis on major cardiovascular events in patients with and without coronary artery disease
    Logstrup, Brian Bridal
    Olesen, Kevin Kris Warnakula
    Masic, Dzenan
    Gyldenkerne, Christine
    Thrane, Pernille Gro
    Ellingsen, Torkell
    Botker, Hans Erik
    Maeng, Michael
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (09) : 1182 - 1188
  • [25] Novel risk factors for cardiovascular disease in rheumatoid arthritis
    Jenny Amaya-Amaya
    Juan Camilo Sarmiento-Monroy
    Ruben-Dario Mantilla
    Ricardo Pineda-Tamayo
    Adriana Rojas-Villarraga
    Juan-Manuel Anaya
    Immunologic Research, 2013, 56 : 267 - 286
  • [26] Novel risk factors for cardiovascular disease in rheumatoid arthritis
    Amaya-Amaya, Jenny
    Camilo Sarmiento-Monroy, Juan
    Mantilla, Ruben-Dario
    Pineda-Tamayo, Ricardo
    Rojas-Villarraga, Adriana
    Anaya, Juan-Manuel
    IMMUNOLOGIC RESEARCH, 2013, 56 (2-3) : 267 - 286
  • [27] Disease Activity Is More Associated with IL-1 Than with IL-6 in Patients with Rheumatoid Arthritis
    Almeida-Santiago, Cristina
    Quevedo-Abeledo, Juan Carlos
    Hernandez-Hernandez, Maria Vanesa
    de Vera-Gonzalez, Antonia
    Gonzalez-Delgado, Alejandra
    Gonzalez-Gay, Miguel Angel
    Ferraz-Amaro, Ivan
    LIFE-BASEL, 2023, 13 (01):
  • [28] IL-6 and IL-21 in Rheumatoid Arthritis
    Carbone, Gustavo
    Wilson, Augusta
    Diehl, Sean
    Bunn, Janice
    Cooper, Sheldon
    Rincon, Mercedes
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S505 - S505
  • [29] The Combination of IL-6 and IL-6 Receptor Levels As a Biomarker of Response to Tocilizumab in Rheumatoid Arthritis Patients
    Diaz-Torne, Cesar
    Ortiz, Maria A.
    Moya, Patricia
    Victoria Hernandez, M.
    Reina, Delia
    Castellvi, Ivan
    Jose De Agustin, Juan
    De La Fuente, Diana
    Corominas, Hector
    Sanmarti, Raimon
    De Llobet Zubiaga, Josep Maria
    Vidal, Silvia
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [30] RISK FACTORS FOR CORONARY HEART DISEASE IN RHEUMATOID ARTHRITIS
    Parvu, M.
    Adascalitei, L. C.
    Coman, S.
    CARDIOLOGY, 2015, 132 : 274 - 274
12345